Heping Li | OMICS International

Journal of Oncology Research and Treatment
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Heping Li


Immunotherapy for Hepatocellular Carcinoma and Its New Development

Hepatocellular Carcinoma (HCC) is the most common primary liver cancer with high mortality. Because of the limitation on the conventional therapeutic options and immunological characters of this disease, variable immunotherapy strategies for HCC have been designed and investigated. A few of them look promising. In this review, we comprehensively su... Read More»

Heping Li, Ildiko Gyory, Xiaoli Zhang, Mingyan Xu and Shiqiu Xiong

: J Oncol Res Treat 2019, 4: 134

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article